Clearside Biomedical CEO George Lasezkay's 2022 pay falls 35% to $1.5M
Clearside Biomedical reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Clearside Biomedical reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Clearside Biomedical received on average a compensation package of $1.1M, a 41% decrease compared to previous year.
Average pay of disclosed executives at Clearside Biomedical
George Lasezkay, Chief Executive Officer, received $1.5M in total, which decreased by 35% compared to 2021. 35% of Lasezkay's compensation, or $532K, was in salary. Lasezkay also received $266K in non-equity incentive plan, $501K in option awards, $214K in stock awards, as well as $19K in other compensation.
Thomas Ciulla, Chief Medical Officer, received a compensation package of $936K, which decreased by 49% compared to previous year. 46% of the compensation package, or $430K, was in salary.
Charles A. Deignan, Chief Financial Officer, earned $876K in 2022, a 43% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2023.